Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART).
about
Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients.Optimal management of cytomegalovirus retinitis in patients with AIDS.Spontaneous resolution of intravitreal steroid-induced bilateral cytomegalovirus retinitisTransporter-targeted lipid prodrugs of cyclic cidofovir: a potential approach for the treatment of cytomegalovirus retinitis.Frosted branch angiitis as a result of immune recovery uveitis in a patient with cytomegalovirus retinitis.Inflammation and outer blood-retina barrier (BRB) compromise following choroidal murine cytomegalovirus (MCMV) infections.
P2860
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART).
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART).
@ast
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART).
@en
type
label
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART).
@ast
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART).
@en
prefLabel
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART).
@ast
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART).
@en
P1476
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART).
@en
P2093
D J Skiest
P304
P356
10.1097/00000441-199905000-00009
P407
P577
1999-05-01T00:00:00Z